|
Temps réel estimé
Cboe BZX
16:40:15 01/09/2026
|
Varia. 5j. | Varia. 1 janv. | ||
| 29,40 USD | +0,39% |
|
-8,20% | +21,61% |
| 10/08 | Le traitement Casdatifan d'Arcus Biosciences pourrait être lancé en 2028, selon Morgan Stanley | MT |
| 10/08 | Arcus Biosciences, Inc. : Morgan Stanley conserve son opinion neutre | ZM |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0,39% | -8,20% | +4,92% | +12,89% | +21,61% | +168,09% | +36,70% | -8,15% | - | 3,73 Md | |
| -0,19% | -2,28% | +2,17% | +15,76% | +6,81% | +0,60% | +17,49% | -25,88% | +208,15% | 49,81 Md | |
| +0,12% | -3,01% | +12,37% | +25,25% | +157,39% | +418,62% | +484,91% | +595,42% | - | 44,06 Md | |
| -0,39% | +0,31% | +11,51% | +39,29% | +15,44% | +41,62% | +16,00% | -0,77% | +236,11% | 42,99 Md | |
| -0,38% | -4,34% | +14,75% | +28,73% | +18,51% | +8,43% | +72,33% | +10,02% | +1 124,63% | 40,88 Md | |
| -0,94% | -1,77% | -0,58% | +2,82% | +9,58% | +18,34% | +46,84% | -21,04% | +153,60% | 33,11 Md | |
| -1,42% | -4,89% | +1,88% | +29,37% | +3,99% | +23,39% | +113,55% | +211,19% | +1 897,09% | 16,58 Md | |
| -0,84% | +3,72% | +7,78% | +19,91% | - | - | - | - | - | 17,27 Md | |
| -0,44% | -2,48% | +6,64% | +16,78% | +15,77% | +11,17% | +27,54% | -40,49% | +100,67% | 14,63 Md | |
| -0,17% | -2,74% | +25,39% | +59,00% | +45,12% | +79,53% | +38,10% | -34,77% | +246,28% | 13,76 Md | |
| -1,17% | -3,36% | +3,04% | +18,26% | -10,42% | -8,22% | -37,86% | -36,79% | +112,40% | 12,73 Md | |
| +0,61% | -7,12% | +38,62% | +20,90% | +8,10% | -18,52% | - | - | - | 11,38 Md | |
| 0,00% | -0,02% | +0,24% | +42,38% | +22,96% | +35,37% | -8,18% | -42,76% | +171,53% | 11,34 Md | |
| -1,10% | -9,75% | +20,24% | +72,51% | +52,30% | +43,09% | +43,09% | -50,17% | - | 10,79 Md | |
| -0,92% | -5,52% | -9,93% | -13,55% | -19,73% | +43,40% | +463,23% | +214,82% | +2 346,84% | 10,6 Md | |
| -0,01% | +0,16% | +0,71% | +70,32% | +78,94% | +256,75% | +446,60% | - | - | 10,19 Md | |
| +0,27% | -5,05% | +10,77% | -19,93% | -23,70% | +4,99% | +49,04% | +49,85% | +100,93% | 10,03 Md | |
| -1,07% | -7,37% | +16,94% | +49,49% | +50,76% | +188,29% | +490,66% | +92,05% | - | 9,88 Md | |
| +7,32% | +11,47% | +101,33% | +198,52% | +192,75% | +105,08% | +97,82% | -1,60% | +1 567,89% | 9,45 Md | |
| +0,76% | -3,70% | +16,01% | +5,75% | +20,25% | +688,64% | +1 404,95% | +19,94% | - | 9,78 Md | |
| Moyenne | +0,00% | -1,87% | +14,24% | +34,72% | +35,08% | +110,98% | +211,27% | +54,76% | +688,84% | 19,15 Md | |
| Moyenne pondérée par Capi. | -0,22% | -1,74% | +11,37% | +29,55% | +37,39% | +100,49% | +168,58% | +85,42% | +571,54% |
- Bourse
- Actions
- Action RCUS
- Secteur Arcus Biosciences, Inc.
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
